MenorrhagiaSymptoms, Doctors, Treatments, Advances & More
Menorrhagia Overview
Learn About Menorrhagia
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
EVMS Health Services
David Archer is a Reproductive Medicine provider in Norfolk, Virginia. Dr. Archer is rated as an Elite provider by MediFind in the treatment of Menorrhagia. His top areas of expertise are Menopause, Menorrhagia, Vaginal Dryness, Hormone Replacement Therapy (HRT), and Intrauterine Device Insertion.
Jacques Donnez practices in Brussels, Belgium. Mr. Donnez is rated as an Elite expert by MediFind in the treatment of Menorrhagia. His top areas of expertise are Uterine Fibroids, Menorrhagia, Infertility, Hysterectomy, and Oophorectomy.
Wellstar MCG Health
Michael Diamond is an Obstetrics and Gynecologist in Augusta, Georgia. Dr. Diamond is rated as an Elite provider by MediFind in the treatment of Menorrhagia. His top areas of expertise are Infertility, Uterine Fibroids, Ovarian Cysts, Hysterectomy, and Endoscopy.
Summary: Objective This study evaluates whether CMS-D002 capsules are effective in treating menorrhagia in participants with uterine fibroids associated with menorrhagia. The primary outcome is the percentage of participants who achieve menstrual blood loss \<80 mL and a reduction of ≥50% from baseline. Study Design This is a placebo-controlled trial. Participants will be randomized to receive either CMS-D...
Summary: The goal of this clinical trial is to determine the benefit of relugolix 40 milligrams (mg) once a day compared with placebo in heavy menstrual bleeding associated with uterine fibroids. The main question\[s\] it aims to answer are: * the benefit of relugolix 40 mg once daily in women with heavy menstrual bleeding associated with uterine fibroids * the safety of relugolix 40 mg once daily in women...


